Improving appropriateness of blood utilization through prospective review of requests for blood products: The role of pathology residents as consultants

Lindsey Haldiman, Hamid Zia, Gurmukh Singh

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: To evaluate the effectiveness of prospective review of orders for fresh-frozen plasma (FFP) and platelets in reducing bloodproduct use, and of the effectiveness of preparing pathology residents to serve as clinical consultants. Design: At our 572-bed tertiary-care hospital, we developed guidelines for the use of blood products in collaboration with a variety of departments. For patients whose condition(s) met generally accepted criteria, we identified trigger points to allow for quick release by blood bank staff of blood products. For patients whose condition(s) did not meet the applicable criteria, the on-call pathology resident reviewed the medical record of that patient to determine whether there were any extenuating circumstances; consulted with the ordering physician and attending pathologist, as needed; and advised the house staff on appropriate use of blood products. We evaluated the change in use of blood products between the years 2009 and 2012 to assess the effectiveness of the program. Results: We observed a decrease of 38.8% and 31.4% in the use of FFP and platelets, respectively (29.7% and 21.1%, respectively, when normalized for the number of discharges). If projected to the national level, this improvement would translate to an annual cost reduction of approximately $130 million. Conclusions: Prospective review of orders for blood products can significantly improve use of these products, thereby reducing risk to patients and avoiding unnecessary healthcare costs. The involvement of pathology residents in the prospective review process provides an excellent opportunity for their training as laboratory consultants.

Original languageEnglish (US)
Pages (from-to)264-271
Number of pages8
JournalLaboratory Medicine
Volume45
Issue number3
DOIs
StatePublished - Jun 1 2014

Fingerprint

Pathology
Consultants
Blood
Platelets
Blood Platelets
Trigger Points
Blood Banks
Hospital beds
Plasmas
Program Evaluation
Tertiary Healthcare
Internship and Residency
Tertiary Care Centers
Health Care Costs
Medical Records
Cost reduction
Guidelines
Physicians
Costs and Cost Analysis
Costs

Keywords

  • Appropriateness of utilization
  • Clinical pathology consultation
  • Fresh frozen plasma
  • Patient safety

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Improving appropriateness of blood utilization through prospective review of requests for blood products : The role of pathology residents as consultants. / Haldiman, Lindsey; Zia, Hamid; Singh, Gurmukh.

In: Laboratory Medicine, Vol. 45, No. 3, 01.06.2014, p. 264-271.

Research output: Contribution to journalArticle

@article{fe34b8b965fd46db81d6b7cf6ef1c2c3,
title = "Improving appropriateness of blood utilization through prospective review of requests for blood products: The role of pathology residents as consultants",
abstract = "Objective: To evaluate the effectiveness of prospective review of orders for fresh-frozen plasma (FFP) and platelets in reducing bloodproduct use, and of the effectiveness of preparing pathology residents to serve as clinical consultants. Design: At our 572-bed tertiary-care hospital, we developed guidelines for the use of blood products in collaboration with a variety of departments. For patients whose condition(s) met generally accepted criteria, we identified trigger points to allow for quick release by blood bank staff of blood products. For patients whose condition(s) did not meet the applicable criteria, the on-call pathology resident reviewed the medical record of that patient to determine whether there were any extenuating circumstances; consulted with the ordering physician and attending pathologist, as needed; and advised the house staff on appropriate use of blood products. We evaluated the change in use of blood products between the years 2009 and 2012 to assess the effectiveness of the program. Results: We observed a decrease of 38.8{\%} and 31.4{\%} in the use of FFP and platelets, respectively (29.7{\%} and 21.1{\%}, respectively, when normalized for the number of discharges). If projected to the national level, this improvement would translate to an annual cost reduction of approximately $130 million. Conclusions: Prospective review of orders for blood products can significantly improve use of these products, thereby reducing risk to patients and avoiding unnecessary healthcare costs. The involvement of pathology residents in the prospective review process provides an excellent opportunity for their training as laboratory consultants.",
keywords = "Appropriateness of utilization, Clinical pathology consultation, Fresh frozen plasma, Patient safety",
author = "Lindsey Haldiman and Hamid Zia and Gurmukh Singh",
year = "2014",
month = "6",
day = "1",
doi = "10.1309/LMSKRN7ND12ZOORW",
language = "English (US)",
volume = "45",
pages = "264--271",
journal = "Laboratory Medicine",
issn = "0007-5027",
publisher = "American Society of Clinical Pathologists",
number = "3",

}

TY - JOUR

T1 - Improving appropriateness of blood utilization through prospective review of requests for blood products

T2 - The role of pathology residents as consultants

AU - Haldiman, Lindsey

AU - Zia, Hamid

AU - Singh, Gurmukh

PY - 2014/6/1

Y1 - 2014/6/1

N2 - Objective: To evaluate the effectiveness of prospective review of orders for fresh-frozen plasma (FFP) and platelets in reducing bloodproduct use, and of the effectiveness of preparing pathology residents to serve as clinical consultants. Design: At our 572-bed tertiary-care hospital, we developed guidelines for the use of blood products in collaboration with a variety of departments. For patients whose condition(s) met generally accepted criteria, we identified trigger points to allow for quick release by blood bank staff of blood products. For patients whose condition(s) did not meet the applicable criteria, the on-call pathology resident reviewed the medical record of that patient to determine whether there were any extenuating circumstances; consulted with the ordering physician and attending pathologist, as needed; and advised the house staff on appropriate use of blood products. We evaluated the change in use of blood products between the years 2009 and 2012 to assess the effectiveness of the program. Results: We observed a decrease of 38.8% and 31.4% in the use of FFP and platelets, respectively (29.7% and 21.1%, respectively, when normalized for the number of discharges). If projected to the national level, this improvement would translate to an annual cost reduction of approximately $130 million. Conclusions: Prospective review of orders for blood products can significantly improve use of these products, thereby reducing risk to patients and avoiding unnecessary healthcare costs. The involvement of pathology residents in the prospective review process provides an excellent opportunity for their training as laboratory consultants.

AB - Objective: To evaluate the effectiveness of prospective review of orders for fresh-frozen plasma (FFP) and platelets in reducing bloodproduct use, and of the effectiveness of preparing pathology residents to serve as clinical consultants. Design: At our 572-bed tertiary-care hospital, we developed guidelines for the use of blood products in collaboration with a variety of departments. For patients whose condition(s) met generally accepted criteria, we identified trigger points to allow for quick release by blood bank staff of blood products. For patients whose condition(s) did not meet the applicable criteria, the on-call pathology resident reviewed the medical record of that patient to determine whether there were any extenuating circumstances; consulted with the ordering physician and attending pathologist, as needed; and advised the house staff on appropriate use of blood products. We evaluated the change in use of blood products between the years 2009 and 2012 to assess the effectiveness of the program. Results: We observed a decrease of 38.8% and 31.4% in the use of FFP and platelets, respectively (29.7% and 21.1%, respectively, when normalized for the number of discharges). If projected to the national level, this improvement would translate to an annual cost reduction of approximately $130 million. Conclusions: Prospective review of orders for blood products can significantly improve use of these products, thereby reducing risk to patients and avoiding unnecessary healthcare costs. The involvement of pathology residents in the prospective review process provides an excellent opportunity for their training as laboratory consultants.

KW - Appropriateness of utilization

KW - Clinical pathology consultation

KW - Fresh frozen plasma

KW - Patient safety

UR - http://www.scopus.com/inward/record.url?scp=84946574687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946574687&partnerID=8YFLogxK

U2 - 10.1309/LMSKRN7ND12ZOORW

DO - 10.1309/LMSKRN7ND12ZOORW

M3 - Article

C2 - 25051081

AN - SCOPUS:84946574687

VL - 45

SP - 264

EP - 271

JO - Laboratory Medicine

JF - Laboratory Medicine

SN - 0007-5027

IS - 3

ER -